| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 81.07B | 81.59B | 78.08B | 74.71B | 71.40B | 69.46B |
| Gross Profit | 38.52B | 37.05B | 35.72B | 34.72B | 33.89B | 33.77B |
| EBITDA | 6.28B | 7.24B | 6.57B | 6.67B | 6.63B | 8.18B |
| Net Income | 2.92B | 3.56B | 3.11B | 3.37B | 3.54B | 4.72B |
Balance Sheet | ||||||
| Total Assets | 56.36B | 54.65B | 52.78B | 50.64B | 46.83B | 45.73B |
| Cash, Cash Equivalents and Short-Term Investments | 14.53B | 9.46B | 9.52B | 5.31B | 6.15B | 7.71B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 15.24B | 15.53B | 15.81B | 15.65B | 11.48B | 13.23B |
| Stockholders Equity | 41.12B | 39.12B | 36.96B | 34.99B | 35.35B | 32.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.78B | 5.71B | 35.53M | -540.55M | 5.95B |
| Operating Cash Flow | 0.00 | 4.29B | 8.58B | 2.53B | 1.59B | 7.30B |
| Investing Cash Flow | 0.00 | -3.00B | -3.05B | -2.64B | -2.41B | -1.87B |
| Financing Cash Flow | 0.00 | -1.36B | -1.32B | -734.96M | -733.82M | -660.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥28.52B | 8.12 | ― | 3.77% | 7.88% | -5.92% | |
65 Neutral | ¥43.11B | 9.40 | ― | 2.19% | 17.90% | 14.14% | |
65 Neutral | ¥215.24B | 27.65 | ― | 0.64% | 57.01% | 91.03% | |
64 Neutral | ¥34.71B | 11.19 | ― | 1.73% | ― | ― | |
62 Neutral | ¥36.17B | 28.55 | 6.70% | 3.84% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥28.95B | 3.19 | ― | 0.95% | 4.14% | ― |